Hyperthermic Intraperitoneal Chemotherapy: Clinical Trials

8 trials of Hyperthermic Intraperitoneal Chemotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 recruiting, 1 withdrawn. 8 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Completed 6, Recruiting 1, Withdrawn 1
Phase 22Completed 2

Follow Hyperthermic Intraperitoneal Chemotherapy: new trials by email Literature Review of Hyperthermic Intraperitoneal Chemotherapy trials Research Report on Hyperthermic Intraperitoneal Chemotherapy

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intraperitoneal LSTA1 in CRS-HIPEC
CRS-HIPEC + LSTA1, CRS-HIPEC alone - Colorectal Cancer, Ovarian Carcinoma
Phase 1WithdrawnUniversity of California, San Diego2023-11-302024-08-20
Raltitrexed in HIPEC
Raltitrexed - Colorectal Cancer, Raltitrexed
Phase 1CompletedFudan University302020-09-182026-02-25
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Biopsy, Cisplatin, Doxorubicin - Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8
Phase 1RecruitingCity of Hope Medical Center492020-08-212026-08-26
A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis
Cisplatin and doxorubicin - Ovarian Cancer
Phase 1CompletedClemens Tempfer152016-11-012022-07-08
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Hyperthermic intraperitoneal chemotherapy (HIPEC), Carboplatin - Ovarian Cancer
Phase 1CompletedLoma Linda University32016-07-142025-05-22
Adjuvant Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Gastric Cancer
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - Locally Advanced Malignant Neoplasm, Gastric Cancer
Phase 1CompletedLoma Linda University42016-02-022019-04-12
Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy
HIPEC - Ovarian Carcinoma, Fallopian Tube Carcinoma
Phase 1 / Phase 2CompletedJules Bordet Institute192010-05-012016-02-24
Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan
cytoreductive surgery and HIPEC - Peritoneal Carcinosis (PC)
Phase 1 / Phase 2CompletedHospices Civils de Lyon182007-06-012025-12-19

Conditions studied

Ovarian Neoplasms (5)  ·  Colorectal Neoplasms (3)  ·  Appendiceal Neoplasms (2)  ·  Peritoneal Neoplasms (2)  ·  Stomach Neoplasms (2)  ·  Fallopian Tube Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Recurrence (1)  ·  Uterine Neoplasms (1)

Sponsors

Loma Linda University (2)  ·  City of Hope Medical Center (1)  ·  Clemens Tempfer (1)  ·  Fudan University (1)  ·  Hospices Civils de Lyon (1)  ·  Jules Bordet Institute (1)  ·  University of California, San Diego (1)

Countries

United States (4)  ·  Belgium (1)  ·  China (1)  ·  France (1)  ·  Germany (1)

Top investigators

Joel Baumgartner (1)  ·  Joseph Kerger, M.D. (1)  ·  Maheswari Senthil, MD (1)  ·  Mazdak Momeni, MD (1)  ·  Mustafa Raoof, MD (1)  ·  Thanh H Dellinger, MD (1)

Results publications

PMID 16394300, PMID 21424369, PMID 21448361, PMID 26811651, PMID 29743140

NIH funding

2014 (1), P30CA033572 (1)